On the brighter side, drug resistance in HCC was suppressed by isocorydine derivative (d-ICD) as it downregulated drug efflux protein and IGF2BP3 (Li et al., 2015; Mancarella and Scotlandi, 2020). Here, IGF2BP3 is linked to hepatocellular carcinoma.